Connect discovery to development with human‑relevant models, advanced analytics, and AI‑powered solutions

Human‑relevant models and spatial profiling deliver more predictive, human‑like data than animal models and 2D cultures, closing the gap between preclinical studies and clinical outcomes. Organoids and 3D cultures better mimic human tissue architecture, improving disease modeling, drug screening, and biomarker discovery.

By combining 3D culture systems with multiplex imaging, spatial profiling, automation, and AI‑driven analysis, you can monitor response continuously, improve early toxicity and efficacy assessment, reduce rework, and move safer, more effective therapies into the clinic faster.

Download eBook ↓

As therapeutic modalities grow more complex, your analytical strategy must characterize identity, purity, potency, stability, and safety at every stage. Integrated LC‑MS, capillary electrophoresis, chromatography, flow cytometry, imaging, and genomics provide the depth and data quality needed to keep advancing the right candidates.

Connected digital data management captures fully traceable, well‑structured data across instruments and sites, enabling faster troubleshooting, smoother tech transfer, and more confident regulatory submissions.

Download eBook ↓

By turning data into a strategic asset and applying advanced analytics and predictive modeling across discovery, development, CMC, and manufacturing, you can identify candidates faster, cut cost and risk, and enable real‑time, cross‑functional decisions that accelerate safer, more effective treatments to patients while strengthening long‑term pipeline resilience.

Download eBook ↓